PatternsRadar
Sign in

ENTEROEntero Healthcare Solutions Limited

NSE
Full chart
1,721.60INR+24.50 (+1.44%)Close · 6 Oct 2026
7 Aug 2026Last results
Consumer ServicesSector
RetailingIndustry
₹7,493 CrMarket cap
44.7P/E (TTM)
51.4%Delivery

Filings & corporate actions

11 results filed
CSV
Next results · Q2 FY27
Expected 7 Nov 2026 – 26 Nov 2026
Estimate: filed 38–57 days after quarter end, last 8 times
2026
  • 7 AugresultsResults · Q1 FY27 · consolidated and standalone+5.8%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026+2.3%NSE
  • 25 MayresultsResults · Q4 FY26 · consolidated and standalone-4.9%NSE
  • 10 AprshareholdingShareholding · 31 Mar 2026+1.4%NSE
  • 12 FebresultsResults · Q3 FY26 · consolidated and standalone-0.7%NSE
  • 19 JanshareholdingShareholding · 31 Dec 2025+0.7%NSE

Reaction to results · all yearsrose on day 0 in 6 of 11 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY277 Aug 2026+5.8%+12.8%+52.8%17.3×
Q4 FY2625 May 2026-4.9%-16.5%-13.8%4.8×
Q3 FY2612 Feb 2026-0.7%-6.7%-13.4%2.9×
Q2 FY2612 Nov 2025+1.1%-5.7%-11.3%4.2×
Q1 FY268 Aug 2025-8.0%-1.1%-7.2%2.5×
Q4 FY2527 May 2025-8.2%-16.6%-22.7%6.2×
Q3 FY2513 Feb 2025-2.3%-0.2%-12.1%1.4×
Q2 FY2513 Nov 2024+0.8%-3.7%+7.5%0.9×
Q1 FY2514 Aug 2024+1.2%+5.2%+16.9%0.7×
Q4 FY2430 May 2024+3.2%+4.0%+6.8%1.3×
Q3 FY249 Mar 2024+2.0%-4.9%-8.4%—
Average-0.9%-3.0%-0.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+38.2%
Profit YoY+72.2%
Interest cost YoY+51.0%
Revenue QoQ+1.6%
Profit QoQ+15.3%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open1,702.00
Day range1,682.70 – 1,744.00
52-week range944.00 – 1,920.00
From 52w high-10.3%
RSI (14)50.4
ATR (14)75.66
Volume63.9K
Avg volume (20D)2.22L
Rel volume0.29×
Volatility (1Y)39.8%
Turnover₹11.0Cr
SMA 50 / 2001,591.60 / 1,261.02

Delivery percentage

Latest · 6 Oct 202651.4%
20-day avg53.9%
1-year avg52.7%
Percentile (own history)33rd
Range16.7–94.7%
Sessions653

Over the last 20 sessions ENTERO settled 53.9% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 52.7%. The latest session ranks higher than 33% of the 653 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryPharmacy Retail

Performance returns

CSV
1D1W1M3M6M1Y
Price+1.44%-3.83%-6.84%+42.27%+37.83%+58.94%

Valuation

CSV
Market cap₹7,493 Cr
P/E (TTM)44.7
EPS (TTM)38.52
Shares outstanding4.35Cr
Listed16 Feb 2024

Ownership

CSV
Promoter52.40%
Promoter Δ QoQ-0.02 pp
Public47.60%
FII4.37%
DII15.48%
Pledged0.00%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)1,570.91,706.51,909.91,940.5
YoY chg+20.8%+25.6%+42.6%+38.2%
Net profit (₹ Cr)36.633.945.152.1
YoY chg+40.6%+15.0%+43.6%+72.2%
Net margin2.3%2.0%2.4%2.7%
EPS7.256.346.438.76

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 52.40% · public 47.60%
15 Feb 2024: promoter 52.44%31 Mar 2024: promoter 52.44%30 Jun 2024: promoter 52.44%30 Sept 2024: promoter 52.44%31 Dec 2024: promoter 52.44%31 Mar 2025: promoter 52.42%30 Jun 2025: promoter 52.42%30 Sept 2025: promoter 52.42%31 Dec 2025: promoter 52.42%31 Mar 2026: promoter 52.42%30 Jun 2026: promoter 52.40%
2024-022026-06
  • Promoter
  • Public and others
Promoter
52.40%
Public
47.60%
Promoter change
-0.02 pp
Filed
21 Jul 2026
FII
4.37%
DII
15.48%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations992.61,034.21,097.01,300.71,359.01,339.11,403.81,570.91,706.51,909.91,940.5
Other income1.89.113.411.37.57.35.84.84.64.03.0
Total income994.41,043.31,110.51,312.01,366.51,346.31,409.61,575.71,711.11,913.91,943.5
Total expenses986.11,029.81,083.21,277.21,327.11,309.11,373.31,531.11,662.61,856.01,876.4
└ Finance costs16.117.39.711.510.010.510.712.414.017.320.6
└ Depreciation6.07.16.67.58.18.58.99.89.814.812.3
Profit before tax8.313.627.334.839.437.236.444.640.457.967.1
Tax expense1.3(7.6)6.88.710.05.86.18.06.512.815.1
Net profit7.021.220.526.029.431.430.236.633.945.152.1
EPS1.915.734.625.435.855.916.397.266.356.448.77
Net margin0.70%2.05%1.87%2.00%2.17%2.35%2.15%2.33%1.99%2.36%2.68%
PBT margin0.84%1.31%2.49%2.67%2.90%2.78%2.59%2.84%2.37%3.03%3.46%
Tax rate16.12%-56.16%24.80%25.14%25.33%15.59%16.86%17.98%16.14%22.12%22.45%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 7 Aug 2026.

ENTERO at a glance

  • ENTERO closed at ₹1,721.6 on 6 Oct 2026, +1.44% on the day, +58.9% over one year, 10.3% below its 52-week high of ₹1,920.
  • Delivery was 51.4% of traded quantity on 6 Oct 2026, the 33rd percentile of its own 653 sessions with a reading (20-session average 53.9%, 1-year average 52.7%).
  • Market capitalisation is ₹7,493 crore at a trailing P/E of 44.7 (trailing EPS ₹38.52).
  • Q1 FY27 results (consolidated, filed 7 Aug 2026): revenue ₹1,940 crore (+38.2% year on year), net profit ₹52 crore (+72.2%); the price moved +5.8% on the first session after.
  • Promoters held 52.40% at 30 Jun 2026, down 0.02 percentage points on the previous filing.
  • Q2 FY27 results are expected between 7 Nov 2026 and 26 Nov 2026, going by past filing dates — an estimate, not an announcement.